https://www.selleckchem.com/pr....oducts/vevorisertib-
Primary outcomes include the diagnostic yield and sensitivity of each biopsy modality and the diagnostic yield of the combined modalities. The CONFIDENT-ENB trial will prospectively evaluate the synergistic effectiveness and comparative accuracy of ENB-guided needle aspiration and forceps biopsy in a least-invasive setting. The results are expected to improve our understanding of the optimal tool-selection strategy for ENB. ClinicalTrials.gov (NCT05110131). Prospectively registered on 5 November 2021. ClinicalTrial
Like
Comment
Share
